Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.

“It’s clear that menopausal symptoms can disrupt women’s lives. With too few practitioners trained in managing menopause, women are underdiagnosed, undertreated, and underserved. Midi provides an insurance-covered solution that focuses on women’s unique needs, closing a major gap in health access, quality, and equity.” Joanna Strober, CEO & Founder of Midi Health. Image: Midi Health


Midi Health secures $25M in Series A funding to advance women’s midlife care.

Evvy raises $14M in Series A funding to grow and evolve its vaginal healthcare platform.

Notify Therapeutics secures €5M for the development of a non-hormonal fertility treatment.

Former Tinder CEO Renate Nybord launches relationship mentoring app Meeno; announces after raising $3.9M seed round.

New report by Carrot sheds light on Menopause’s impact on women’s careers.

Blue Cross and Blue Shield of Texas awards $1.2M grant to March of Dimes for a Mom & Baby Mobile Health Center in Texas.

InsideTracker unveils new DNA insights focused on menopausal age, bone density, and more.

Venture capital firm age1 raises $35M to advance longevity-focused biotech.

In the Know

Four Years and Counting. It’s Femtech Insider’s Birthday Today! 🎉

How Flowsense Empowers Visually Impaired Women to Independently Manage Their Menstrual Cycle (Femtech Insider)

4 Black Female OB-GYNs Take on Racial Disparities in Reproductive Health (Proto.Life)

Treating Rural America: The last doctor in town (STAT News)

The Calendar of Human Fertility Is Changing (The Atlantic)

Interest in doula care grows amid maternal health crisis (Axios)

Even the most popular femtech apps are still leaving African women behind (TechCabal)

What it will take to eliminate disparities in fertility care for Black women (Axios)

Show CommentsClose Comments

Leave a comment